Open original FDA record ↗Recall record
- FDA identifier
- Z-0401-2021
- Company in FDA record
- Merz North America, Inc.
- FDA record creation date
- Nov 16, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.
Source facts
- Action
- Merz NA, in cooperation with Boston Scientific Corporation (BSC) have prepared field action communications including a Medical Device Field Notification Letter and Urgent Medical Device Field Notification Response Form. These letters will be sent via FedEx with delivery confirmation. The units at consignees will not be returned but will be furnished with an updated, revision-controlled IFU.
- Initiated
- 2020-09-30
- Root cause
- Labeling design
- Distribution
- US only distribution - AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV
- Recall number
- Z-0401-2021
- Recall status
- Open, Classified
- CDRH record ID
- 184068
- FDA record created
- 2020-11-16
- Recall event number
- 86572